- Home
- TXG vs JBGS Comparison
TXG vs JBGS Comparison
Compare TXG & JBGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TXG
- JBGS
- Stock Information
- Founded
- TXG 2012
- JBGS 2016
- Country
- TXG United States
- JBGS United States
- Employees
- TXG N/A
- JBGS N/A
- Industry
- TXG Biotechnology: Laboratory Analytical Instruments
- JBGS Real Estate Investment Trusts
- Sector
- TXG Industrials
- JBGS Real Estate
- Exchange
- TXG Nasdaq
- JBGS Nasdaq
- Market Cap
- TXG 1.3B
- JBGS 1.3B
- IPO Year
- TXG 2019
- JBGS 2017
- Fundamental
- Price
- TXG $8.85
- JBGS $16.50
- Analyst Decision
- TXG Buy
- JBGS Sell
- Analyst Count
- TXG 16
- JBGS 2
- Target Price
- TXG $20.00
- JBGS $16.00
- AVG Volume (30 Days)
- TXG 3.0M
- JBGS 1.4M
- Earning Date
- TXG 04-29-2025
- JBGS 04-29-2025
- Dividend Yield
- TXG N/A
- JBGS 4.29%
- EPS Growth
- TXG N/A
- JBGS N/A
- EPS
- TXG N/A
- JBGS N/A
- Revenue
- TXG $610,785,000.00
- JBGS $546,890,000.00
- Revenue This Year
- TXG $1.43
- JBGS N/A
- Revenue Next Year
- TXG $8.86
- JBGS $7.15
- P/E Ratio
- TXG N/A
- JBGS N/A
- Revenue Growth
- TXG N/A
- JBGS N/A
- 52 Week Low
- TXG $8.53
- JBGS $13.65
- 52 Week High
- TXG $37.74
- JBGS $18.86
- Technical
- Relative Strength Index (RSI)
- TXG 33.15
- JBGS 63.51
- Support Level
- TXG $9.65
- JBGS $15.74
- Resistance Level
- TXG $10.60
- JBGS $16.12
- Average True Range (ATR)
- TXG 0.51
- JBGS 0.53
- MACD
- TXG -0.06
- JBGS 0.11
- Stochastic Oscillator
- TXG 13.68
- JBGS 96.38
About TXG 10x Genomics Inc.
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives maximum revenue from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).
About JBGS JBG SMITH Properties
JBG SMITH Properties is a real estate investment trust based in the United States. It owns, operates, invests in and develops real estate assets concentrated in urban infill submarkets in and around Washington, DC. In addition, the company also provides fee-based real estate services to the legacy funds through its third-party real estate services business. The operating segments of the company are commercial, multifamily and third-party asset management and real estate services. The company generates majority of its revenue from Commercial segment.